TCL Archive In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs May 30, 1980
TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive New Opportunities Still Abound In Immunology Program, Terry and other NCI Executives Say February 27, 1976